NCT ID | NCT02983604 |
Title | GS-5829 in Combination With Exemestane or Fulvestrant Comparing With Exemestane or Fulvestrant Alone in Women With Advanced Estrogen Receptor Positive HER2- Breast Cancer |
Recruitment | Terminated |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | yes |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | senior adult |